These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9142206)

  • 1. Delayed-accelerated hyperfractionated radiation therapy for advanced-stage or high-risk rhabdomyosarcoma.
    Merchant TE
    Med Pediatr Oncol; 1997 Jul; 29(1):45-50. PubMed ID: 9142206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose escalation using twice-daily radiotherapy for nasopharyngeal carcinoma: does heavier dosing result in a happier ending?
    Jen YM; Lin YS; Su WF; Hsu WL; Hwang JM; Chao HL; Liu DW; Chen CM; Lin HY; Wu CJ; Chang LP; Shueng PW
    Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):14-22. PubMed ID: 12182970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II trial evaluating selective use of altered radiation dose and fractionation in patients with unresectable rhabdomyosarcoma.
    Regine WF; Fontanesi J; Kumar P; Zeitzer K; Greenwald C; Bowman L; Shapiro DN; Rao BN; Kun LE
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):799-805. PubMed ID: 7860391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary results of alternating combination chemotherapy (CT) and hyperfractionated radiotherapy (HART) in advanced rhabdomyosarcoma (RMS).
    Mandell LR; Ghavimi F; Exelby P; Fuks Z
    Int J Radiat Oncol Biol Phys; 1988 Jul; 15(1):197-203. PubMed ID: 2455700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperfractionated radiation in children with rhabdomyosarcoma--results of an Intergroup Rhabdomyosarcoma Pilot Study.
    Donaldson SS; Asmar L; Breneman J; Fryer C; Glicksman AS; Laurie F; Wharam M; Gehan EA
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):903-11. PubMed ID: 7607964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of alternating chemotherapy and hyperfractionated radiation therapy in childhood rhabdomyosarcoma.
    Merchant TE; Cahill JC; Ghavimi F
    Med Pediatr Oncol; 1998 Jun; 30(6):332-8. PubMed ID: 9589081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma--a report from the IRSG.
    Donaldson SS; Meza J; Breneman JC; Crist WM; Laurie F; Qualman SJ; Wharam M;
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):718-28. PubMed ID: 11597814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiocurability of microscopic disease in childhood rhabdomyosarcoma with radiation doses less than 4,000 cGy.
    Mandell L; Ghavimi F; Peretz T; LaQuaglia M; Exelby P
    J Clin Oncol; 1990 Sep; 8(9):1536-42. PubMed ID: 2391558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term results of three-dimensional conformal radiation therapy for patients with rhabdomyosarcoma.
    Wolden SL; La TH; LaQuaglia MP; Meyers PA; Kraus DH; Wexler LH
    Cancer; 2003 Jan; 97(1):179-85. PubMed ID: 12491519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group trials II through IV.
    Michalski JM; Meza J; Breneman JC; Wolden SL; Laurie F; Jodoin M; Raney B; Wharam MD; Donaldson SS
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1027-38. PubMed ID: 15234036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different risks of symptomatic brain necrosis in NPC patients treated with different altered fractionated radiotherapy techniques.
    Jen YM; Hsu WL; Chen CY; Hwang JM; Chang LP; Lin YS; Su WF; Chen CM; Liu DW; Chao HL
    Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):344-8. PubMed ID: 11567807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperfractionated radiotherapy in locally advanced nasopharyngeal cancer. An analysis of 43 consecutive patients.
    Jereczek-Fossa BA; Morra A; DeBraud F; Alterio D; Mazzetta C; Rocca A; Catalano G; Bianchi L; Pasetti M; Chiesa F; Bruschini R; Orecchia R
    Strahlenther Onkol; 2004 Jul; 180(7):425-33. PubMed ID: 15241530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative cisplatin and accelerated hyperfractionated radiation induces high tumor response and control rates in patients with advanced head and neck cancer.
    Wanebo HJ; Glicksman AS; Landman C; Slotman G; Doolittle C; Clark J; Koness RJ
    Am J Surg; 1995 Nov; 170(5):512-6. PubMed ID: 7485745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local control after intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma.
    Curtis AE; Okcu MF; Chintagumpala M; Teh BS; Paulino AC
    Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):173-7. PubMed ID: 18501529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed resection in the management of non-orbital rhabdomyosarcoma of the head and neck in childhood.
    Blatt J; Snyderman C; Wollman MR; Mirro J; Janecka IP; Albo VC; Deutsch M; Janosky JE; Wiener ES
    Med Pediatr Oncol; 1997 Apr; 28(4):294-8. PubMed ID: 9078331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancer.
    Dobrowsky W; Naudé J; Widder J; Dobrowsky E; Millesi W; Pavelka R; Grasl C; Reichel M
    Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):803-6. PubMed ID: 9845100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation therapy target volume reduction in pediatric rhabdomyosarcoma: implications for patterns of disease recurrence and overall survival.
    Eaton BR; McDonald MW; Kim S; Marcus RB; Sutter AL; Chen Z; Esiashvili N
    Cancer; 2013 Apr; 119(8):1578-85. PubMed ID: 23280478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I dose escalating trial of hyperfractionated pre-operative chemoradiation for locally advanced rectal cancer.
    Movsas B; Hanlon AL; Lanciano R; Scher RM; Weiner LM; Sigurdson ER; Hoffman JP; Eisenberg BL; Cooper HS; Provins S; Coia LR
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):43-50. PubMed ID: 9747818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.